HanchorBio Inc. (7827)
TWSE
Closed
Jul 29, 2026
Day's Range
133.0052 wk Range
63.70Overview - 7827 - HanchorBio Inc.
Key Statistics
Valuation
Enterprise Value
18.04B
Price / Sales (TTM)
‪64.83‬
Price / Book
‪24.74‬
EV / EBITDA
‪-54.96‬
Profitability
Profit Margin
‪-159.37%‬
Operating Margin
‪39.19%‬
Return on Assets
‪-23.61%‬
Return on Equity
‪-31.83%‬
Ownership
Shares Outstanding
130.01M
Price stats
50-Day Avg
‪137.10‬
200-Day Avg
‪107.35‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 7827 - HanchorBio Inc.
Peers - 7827 - HanchorBio Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 7827TWSEHanchorBio Inc.19.68BMarket Cap+42.27%52-week change—P/E (Trailing)‪-159.37%‬Profit Margin
- 6949TWSEPell Bio-Med Technology Co., Ltd.88.80BMarket Cap+70.92%52-week change-187.41P/E (Trailing)‪-13.97%‬Profit Margin
- 6696TWSELin BioScience, Inc.77.69BMarket Cap+83.89%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6586TWSECho Pharma Inc.23.96BMarket Cap+66.20%52-week change—P/E (Trailing)‪74.49%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.22.82BMarket Cap-54.32%52-week change384.62P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.83BMarket Cap-2.00%52-week change30.17P/E (Trailing)‪35.54%‬Profit Margin
Profile Summary - 7827 - HanchorBio Inc.
About
HanchorBio Inc. is a biotechnology company established in 2020 and headquartered in Taipei, Taiwan. Specializing in immuno-oncology, HanchorBio is dedicated to developing next-generation biologic therapies designed to enhance and harness the immune system's ability to combat cancer. The company's core innovation lies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
